The head of the Federal Trade Commission or FTC, Lina Khan, has revealed that she successfully contested a medical bill using OpenAI’s ChatGPT.
What Happened: Khan, who is known for her criticism of big tech firms and her advocacy for AI regulation, shared her successful experience while using AI on the New York Times’ Hard Fork podcast, reported Business Insider.
When asked about her personal experience with AI, she said, “I’d read somewhere that somebody had gotten it to very effectively start contesting medical bills, which I had been navigating,” adding, “And so I entered some of those prompts and actually got a successful outcome.”
See Also: Steve Jobs’ Sharp Reply To A Customer With A Wet MacBook Pro Shows His No-Nonsense Style
Khan, who assumed the role of chair for the FTC in 2021, didn’t elaborate on the matter, but her disclosure made it clear that the chatbot is being used by users worldwide for various applications.
This is not the first instance of high-profile usage of ChatGPT.
The AI program had previously outperformed human staff writers when California Governor Gavin Newsom’s team used it for speechwriting. However, the governor did not use AI-generated content verbatim due to its ability to “hallucinate” and provide made-up facts convincingly.
Why It Matters: Regarding AI regulations, last month, U.S. President Joe Biden signed a landmark executive order establishing new standards for AI safety and security.
While the order has received praise from many people, it has also received some concerns from Cathie Wood’s Ark Investment and Yann LeCun, one of the three “Godfathers of AI” and Meta’s chief AI scientist.
Photo by Ascannio on Shutterstock
Check out more of Benzinga’s Consumer Tech coverage by following this link.
Read Next: Elon Musk Helped Found ChatGPT, But Now He Thinks It Has Become ‘Insufferable.’ What’s On With That?
This content was partially produced with the help of Benzinga Neuro and was reviewed and published by Benzinga editors.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.